Live Breaking News & Updates on Learmind Medicine Inc

Stay updated with breaking news from Learmind medicine inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Clearmind Medicine Submits Three Additional International

New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) . ....

British Columbia , United States , Adi Zuloff Shani , Clearmind Medicine Inc , Medicine Inc , Trademark Office , Canadian Securities Exchange , Frankfurt Stock Exchange , Scisparc Ltd , Patent Cooperation Treaty , United States Patent , Chief Executive Officer , Nasdaq Cmnd , Learmind Medicine Inc ,

Clearmind Medicine Receives Approval to Commence its Phase

For the first time, patients with alcohol use disorder will receive the company s unique and proprietary psychedelic - MEAI Vancouver, Canada, Feb. 23,. ....

Ramat Gan , Tel Aviv , British Columbia , United States , Adi Zuloff Shani , Mark Weiser , Canadian Securities Exchange , Medicine Inc , Johns Hopkins University School Of Medicine , Clearmind Medicine Inc , Frankfurt Stock Exchange , Psychiatric Division , Yale School Of Medicine Department Psychiatry , Ministry Of Health Israel , Sheba Medical Center , Yale School , Johns Hopkins University School , Nasdaq Cmnd , Learmind Medicine Inc ,

Clearmind Medicine Inc. Announces Pricing of $2.4 Million

TEL AVIV, ISRAEL / VANCOUVER, CANADA, Jan. 11, 2024 (GLOBE NEWSWIRE) Clearmind Medicine Inc. (NASDAQ: CMND) (the “Company”), a biotech company focused. ....

United States , New York , Daniel Bloch , Kaufman Canoles , Frankfurt Stock Exchange , Exchange Commission , Canadian Securities Exchange , Aegis Capital Corp , Clearmind Medicine Inc , Greenberg Traurig , Syndicate Department , Common Shares , Pre Funded Units , Common Share , Pre Funded Warrant , Common Unit , Pre Funded Unit , Pre Funded Warrants , Common Units , Exclusive Placement Agent , Placement Agent , Securities Act , Private Securities Litigation Reform Act , Nasdaq Cmnd , Learmind Medicine Inc , Aegis Capital Corp ,

Clearmind Medicine Announces Pricing of US$2.25 Million

Tel Aviv, Israel / Vancouver, Canada, Sept. 14, 2023 (GLOBE NEWSWIRE) Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a. ....

United States , Tel Aviv , New York , Aegis Capital Corp , Canadian Securities Exchange , Frankfurt Stock Exchange , Clearmind Medicine Inc , Exchange Commission , Nasdaq Cmnd , Learmind Medicine Inc ,

Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering

Tel Aviv, Israel / Vancouver, Canada, Sept. 14, 2023 (GLOBE NEWSWIRE) Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the pricing of its United States only public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately US$2.25 million, before dedu ....

United States , New York , Tel Aviv , Aegis Capital Corp , Canadian Securities Exchange , Frankfurt Stock Exchange , Clearmind Medicine Inc , Exchange Commission , The Company , Learmind Medicine Inc , Common Shares , Clearmind Medicine Inc ,